Thursday, August 13, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
MarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%todayBusiness & M&AGalderma Raises 2026 Guidance After Robust H12 days agoMarketHugel Posts Record H1 Revenue on Overseas Toxin SurgetodayBusiness & M&AIndonesia Opens First Botulinum Toxin Plant2 days agoDevices & TechInMode Q2 Revenue Beats at $95.6M on Device DemandtodayRegulatoryBotox Masseter Indication Moves Closer to FDA OK2 days agoInjectablesEvolus' Injectable Platform Is Becoming Its Real MoattodayMarketSouth Korea's Big Three Post ₩225.9B Q2 Revenue2 days agoDevices & TechUltherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&AAllergan Refreshes Partner Privileges Loyalty ProgramyesterdayBusiness & M&AEvolus Tops Q2 Revenue Forecast, Raises 2026 OutlookyesterdayDevices & TechApyx Sees GLP-1 Boom Fueling Body Contouring Demandyesterday
1 free article left this week. A free account gets you 4 a week.Go Pro →
Injectables

FDA Approves Skinvive by Juvéderm for Neck Appearance — AbbVie Expands Filler Portfolio Beyond Face

Allergan Aesthetics gains clearance for injectable to improve neck lines and skin quality, opening a new revenue line for practices.

Image: Inside MedSpa
1-YEAR MOVE
+15% −13%
ABBV ▲11.6%
1-year price move by ticker
TickerCompany1-year change
ABBVAbbVie (Allergan Aesthetics)+11.6%

The FDA has approved Skinvive by Juvéderm for improvement of neck appearance, marking the first indication outside facial rejuvenation for AbbVie's hyaluronic acid filler platform. The product is positioned as a smooth, injectable gel designed to address neck lines and skin texture — a clinical gap many practices have managed off-label or deferred to energy devices.

First Juvéderm indication outside facial rejuvenation opens a new revenue line for practices.

For medspa owners, this approval matters operationally: it legitimizes neck treatment as a distinct revenue stream, supports insurance coding discussions (though most aesthetic procedures remain cash), and gives you a branded, cleared product to market alongside your existing Juvéderm portfolio. Skinvive integrates into Allē loyalty economics, so rebate and pricing moves from AbbVie will flow through your per-syringe margin just as they do for Voluma and Ultra Plus.

Source: original report ↗

Frequently asked questions

What is Skinvive by Juvéderm used for?

Skinvive is an FDA-approved injectable hyaluronic acid filler designed to improve neck appearance by addressing neck lines and skin texture. It's the first Juvéderm product cleared for a non-facial indication, filling a clinical gap that practices previously managed off-label or with energy devices.

How does Skinvive pricing and rebates work for my practice?

Skinvive integrates into AbbVie's Allē loyalty program, meaning rebate structures and pricing moves flow through your per-syringe margin just like other Juvéderm products such as Voluma and Ultra Plus. Most aesthetic procedures remain cash-pay, so you'll manage pricing independently while tracking rebate benefits.

Can I bill insurance for Skinvive neck treatments?

While Skinvive now has FDA clearance for neck appearance, most aesthetic procedures remain cash-based and are not covered by insurance. However, the approval supports clearer insurance coding discussions if a patient pursues coverage, though reimbursement is unlikely for cosmetic indications.

Is Skinvive the only FDA-approved filler for neck lines?

Skinvive is the first Juvéderm product approved specifically for neck appearance, making it a branded option with regulatory backing. However, practices have historically treated neck lines off-label with other fillers or energy-based devices; Skinvive now provides a cleared alternative.

How does adding Skinvive expand my medspa revenue?

Skinvive legitimizes neck treatment as a distinct, billable service line separate from facial rejuvenation, allowing you to market it as a branded, FDA-cleared offering. Combined with your existing Juvéderm portfolio, it creates cross-selling opportunities and addresses a clinical gap many patients defer or seek elsewhere.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/skinvive-juvéderm-fda-approval-neck-appearance/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo